Repeat Immune Checkpoint Inhibitor Therapy Not Recommended for Advanced Kidney Cancer
Antibody-Drug Conjugate Found Effective Against Brain Metastases in Patients with HER2-Positive Breast Cancer
Comprehensive Cancer Research from Dana-Farber Leads ESMO Congress 2024
Powerful New Mini Microscopic Will Enable Precision Cancer Surgery
Pancreatic Cancer: Study Finds Most Early Staging Inaccurate
Adolescent Glioma Subtype Responds to CDK4/6 Inhibitor
Dana-Farber President and CEO Laurie Glimcher, MD, Announces Her Plans to Step Down Capping a Highly Successful Tenure Marked with Discovery and Innovation
Exclusive to Roswell Park, ‘Armored CAR’ Clinical Trial Targets CD19+ Hematologic Malignancies
Prostate Cancer Surveillance, Treatment Disparities Among Urology Conference Talks
Early Action, Better Outcomes: Transforming Cancer Prevention
Scientific Stunt Double: How a Molecular Twin Is Changing Cancer Treatment, Research
Panel Issues First Guidelines to Prevent Anal Cancer in People With HIV
Next Generation Armored Car T-Cell Therapy Trial Now Open
Roswell Park Ranked by Forbes Among America’s Best Employers for Women 2024
FDA Expands Orphan Drug Designation for SurVaxM, Immunotherapy Developed at Roswell Park.
Showing 16 - 30 of 1027 results
Previous| 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 ...69 |Next
Cancer
Cardiology
Gastroenterology
Neurology
OBGYN
Orthopedics
Pediatrics
BroadcastMed News
Dermatology
Diabetes & Endocrinology
Infectious Diseases
Ophthalmology
Optometry
Otolaryngology
Pulmonology
Surgery
Urology
About
Solutions
Resources
Contact
person Sign In / Create Account
